Martin Shkreli livestreamed himself violating lifetime pharma ban, FTC says

Image: The Guardian
ad slot · in-content video 16:9
Coverage
Wires & papers of record
- Martin Shkreli’s 2022 release conditions bar him from participating in the pharmaceutical industry, including ownership stakes or business decisions The Federal Trade Commission (FTC) and seven US states have alleged that pharmaceutical executive Martin Shkreli repeatedly violated a lifetime ban…
Coverage
- The controversial investor has been weighing in on biopharma stocks even though he’s banned from doing so.
- "I can always find a couple of biotech stocks to smoke," Shkreli said in a livestream.